U.S. Markets closed

Pfizer Inc. (PFE)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
32.12-0.34 (-1.05%)
At close: 4:00PM EDT

32.13 0.01 (0.03%)
After hours: 7:54PM EDT

People also watch
MRKJNJJPMGEINTC

Pfizer Inc.

235 East 42nd Street
New York, NY 10017
United States
212-733-2323
http://www.pfizer.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees96,500

Key Executives

NameTitlePayExercisedAge
Mr. Ian C. ReadChairman and Chief Exec. Officer6.38M11.48M63
Mr. Frank A. D'AmelioChief Financial Officer and Exec. VP of Bus. Operations3.24M6.11M60
Dr. Mikael Dolsten M.D., Ph.D.Pres of Worldwide R&D4.2M3.33M58
Mr. John D. YoungGroup Pres of Pfizer Essential Health4.42M1.15M52
Mr. Albert Bourla DVM, Ph.D.Group Pres of Pfizer Innovative Health4.07M587.28k55
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates through two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Viagra, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that will lose or have lost marketing patent protection; branded generic products; sterile injectable products; biosimilars; and infusion systems. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, and Pristiq brand names. This segment also engages in contract manufacturing business. The company has licensing agreements with Cellectis SA and AstraZeneca plc; and collaborative agreements with Eli Lilly & Company and Merck KGaA. It also has a research collaboration and license agreement with HitGen Ltd. to build and screen DNA-encoded libraries in order to discover small molecule leads to be used in drug development; and an agreement with InSphero AG to develop a predictive toxicology assay using InSphero 3D InSight human liver microtissues for predicting drug induced liver injury. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Corporate Governance

Pfizer Inc.’s ISS Governance QualityScore as of May 1, 2017 is 1. The pillar scores are Audit: 2; Board: 5; Shareholder Rights: 2; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.